- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge names new vice presidents
Merge Technologies has appointed Beth Frost-Johnson vice president of marketing and David M. Noshay vice president of its business unit. The executives will be charged with expanding Merge’s position in the PACS and radiology workflow solutions
Merge Technologies has appointed Beth Frost-Johnson vice president of marketing and David M. Noshay vice president of its business unit. The executives will be charged with expanding Merge’s position in the PACS and radiology workflow solutions sectors. Frost-Johnson has more than 20 years’ marketing experience in the healthcare industry, most recently with Click4Care, where she drove the marketing and client efforts of the business-to-business-to-consumer healthcare ASP. She also served in numerous marketing positions in the healthcare delivery industry. Noshay, who joined Merge six years ago, has served in various capacities, most recently as vice president of strategic marketing.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
